Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07340047 · ClinicalTrials.gov registry record · Phase 1
H1ssF Flu Vaccine Clinical Trial
A Phase 1 study, sponsored by University of Minnesota.
- Not yet
- Registry status
- Phase 1
- Development phase
- 112
- Enrollment target
NCT07340047 is a Phase 1 study that has not yet begun recruiting, run by University of Minnesota. The registered enrollment target is 112 participants.
The verdict
NCT07340047, a Phase 1 study, has not yet begun recruiting, sponsored by University of Minnesota.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 112 participants
- Enrollment target
Study Summary
This is a two-arm, open-label, randomized, phase 1, controlled clinical trial intended to evaluate the safety and immunologic response to the experimental vaccine H1ssF (H1 stabilized stem ferritin nanoparticle) and the seasonal flu vaccine Flucelvax.
Interventions
- BIOLOGICAL H1ssF vaccine
- BIOLOGICAL Flucelvax seasonal vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2028-03-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07340047
The ClinicalTrials.gov registry entry for NCT07340047 describes a study currently listed as not yet recruiting, categorized as Phase 1. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which H1ssF vaccine is the first listed.
NCT07340047 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07340047 about?
NCT07340047 is a clinical study titled "H1ssF Flu Vaccine Clinical Trial". This is a two-arm, open-label, randomized, phase 1, controlled clinical trial intended to evaluate the safety and immunologic response to the experimental vaccine H1ssF (H1 stabilized stem ferritin nanoparticle) and the seasonal flu vaccine Flucelvax.
What is the current status of trial NCT07340047?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 112 participants. The study started on 2026-08-01. Estimated completion is 2028-03-01.
What interventions are being tested in trial NCT07340047?
The interventions under investigation include: H1ssF vaccine (BIOLOGICAL), Flucelvax seasonal vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT07340047?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.